Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Medical Oncology, Medicine, Stanford University 1987 - 1990
  • Medical Resident, Medicine, Vanderbilt University 1983 - 1986
  • M.D., Wake Forest University 1983
  • M.S., Wake Forest University 1979
• 

  Previous Appointments & Affiliations

  • Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2011 - 2020
  • Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2010 - 2011
  • Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2005 - 2010
  • Instructor, Temporary in the Department of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2004 - 2005
  • Associate Clinical Professor of Medicine, Medicine, Medical Oncology, Medicine 1998 - 2003
  • Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 1997 - 1998
• Research
• 

  Selected Grants

  • BEAT-MS awarded by Benaroya Research Institute at Virginia Mason 2021 - 2028
  • An Open-label Pilot Multicenter Study to Evaluate the Safety and Efficacy of ADCT-301 in Patients with Relapsed or Refractory CD25-positive Acute Myeloid Leukemia, myelodysplastic syndrome, or myeloproliferative neoplasms awarded by ADC Therapeutics Sarl 2020 - 2025
  • A Phase I Open Label Study of Panobinostat in combination with Lenalidomide, Bortezomib, and Dexamethasone in patients with relapsed and relapsed/refractory Multiple Myeloma awarded by Dana-Farber/Partners CancerCare, Inc. 2014 - 2024
  • BEAT-MS awarded by Immune Tolerance Network 2020 - 2021
  • A Randomized, Dbl-Blind, Placebo-Controlled, Parallel-Grp, Multictr, Ph 3 Study-Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients awarded by Chimerix, Inc. 2013 - 2016
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kang, Yubin, Pasupathi Sundaramoorthy, Cristina Gasparetto, Daniel Feinberg, Shengjun Fan, Gwynn Long, Emily Sellars, et al. “Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.” Ann Hematol, December 3, 2022. https://doi.org/10.1007/s00277-022-05056-7.
       Full Text  Link to Item
    • Lew, Meagan V., Yi Ren, Yen P. Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M. Romero, Jillian C. Thompson, et al. “Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.” Transplant Cell Ther 28, no. 8 (August 2022): 498.e1-498.e9. https://doi.org/10.1016/j.jtct.2022.05.018.
       Full Text  Link to Item
    • Sung, Anthony D., Vinay K. Giri, Helen Tang, Krista Rowe Nichols, Meagan V. Lew, Lauren Bohannon, Yi Ren, et al. “Home-Based Hematopoietic Cell Transplantation in the United States.” Transplant Cell Ther 28, no. 4 (April 2022): 207.e1-207.e8. https://doi.org/10.1016/j.jtct.2022.01.015.
       Full Text  Link to Item
    • Islam, Prioty, Helen Tang, Haesu Jin, Felicia Cao, Lauren M. Bohannon, Yi Ren, Nelson J. Chao, et al. “Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.” Transplant Cell Ther 27, no. 9 (September 2021): 784.e1-784.e7. https://doi.org/10.1016/j.jtct.2021.06.012.
       Full Text  Link to Item
    • Bohannon, Lauren, Helen Tang, Kristin Page, Yi Ren, Sin-Ho Jung, Alexandra Artica, Anne Britt, et al. “Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.” Transplant Cell Ther 27, no. 8 (August 2021): 669.e1-669.e8. https://doi.org/10.1016/j.jtct.2021.05.002.
       Full Text  Open Access Copy  Link to Item
    • Pabon, Cindy M., Zhiguo Li, Therese Hennig, Carlos de Castro, Jadee L. Neff, Mitchell E. Horwitz, Thomas W. LeBlanc, et al. “Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.” Blood Cancer J 11, no. 5 (May 16, 2021): 92. https://doi.org/10.1038/s41408-021-00481-9.
       Full Text  Open Access Copy  Link to Item
    • Giri, Vinay K., Kristin G. Kegerreis, Yi Ren, Lauren M. Bohannon, Erica Lobaugh-Jin, Julia A. Messina, Anita Matthews, et al. “Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.” Transplant Cell Ther 27, no. 3 (March 2021): 262.e1-262.e11. https://doi.org/10.1016/j.jtct.2021.01.004.
       Full Text  Link to Item
    • Racioppi, Alessandro, Tara Dalton, Sendhilnathan Ramalingam, Kristi Romero, Yi Ren, Lauren Bohannon, Consuelo Arellano, et al. “Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.” Transplant Cell Ther 27, no. 2 (February 2021): 181.e1-181.e9. https://doi.org/10.1016/j.jtct.2020.10.017.
       Full Text  Link to Item
    • Maung, Ko K., Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, et al. “Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.” Bone Marrow Transplant 56, no. 1 (January 2021): 137–43. https://doi.org/10.1038/s41409-020-0991-5.
       Full Text  Link to Item
    • Ramalingam, Sendhilnathan, Sharareh Siamakpour-Reihani, Lauren Bohannan, Yi Ren, Alexander Sibley, Jeff Sheng, Li Ma, et al. “A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.” Plos One 16, no. 6 (2021): e0252995. https://doi.org/10.1371/journal.pone.0252995.
       Full Text  Link to Item
    • Smith, Patrick, Jillian C. Thompson, Elena Perea, Brian Wasserman, Lauren Bohannon, Alessandro Racioppi, Taewoong Choi, et al. “Clinical and Neuroimaging Correlates of Post-Transplant Delirium.” Biol Blood Marrow Transplant 26, no. 12 (December 2020): 2323–28. https://doi.org/10.1016/j.bbmt.2020.09.016.
       Full Text  Link to Item
    • Maertens, Johan, Aaron C. Logan, Junho Jang, Gwynn Long, Jih-Luh Tang, William Y. K. Hwang, Liang Piu Koh, et al. “Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.” Antimicrob Agents Chemother 64, no. 4 (March 24, 2020). https://doi.org/10.1128/AAC.02467-19.
       Full Text  Link to Item
    • Maung, Ko, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, et al. “Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.” Plos One 15, no. 9 (2020): e0238824. https://doi.org/10.1371/journal.pone.0238824.
       Full Text  Link to Item
    • Cardones, Adela R., Keith M. Sullivan, Cindy Green, Nelson J. Chao, Krista Rowe-Nichols, Lionel L. Bañez, Claude S. Burton, et al. “Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.” Jama Dermatol 155, no. 7 (July 1, 2019): 833–37. https://doi.org/10.1001/jamadermatol.2018.5459.
       Full Text  Link to Item
    • Sivaraj, Dharshan, Michael M. Green, Yubin Kang, Gwynn D. Long, David A. Rizzieri, Zhiguo Li, Anderson H. Garrett, Jackie L. McIntyre, Nelson J. Chao, and Cristina Gasparetto. “Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma.” Blood Cancer J 8, no. 8 (July 31, 2018): 71. https://doi.org/10.1038/s41408-018-0104-5.
       Full Text  Link to Item
    • Sivaraj, D., W. Bacon, G. D. Long, D. A. Rizzieri, M. E. Horwitz, K. M. Sullivan, Y. Kang, Z. Li, N. J. Chao, and C. Gasparetto. “High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.” Bone Marrow Transplant 53, no. 1 (January 2018): 34–38. https://doi.org/10.1038/bmt.2017.208.
       Full Text  Link to Item
    • Huang, Li-Wen, Wendi Bacon, Constance Cirrincione, Bercedis Peterson, Gwynn Long, David Rizzieri, Keith M. Sullivan, et al. “Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.” Hematol Oncol 35, no. 4 (December 2017): 752–59. https://doi.org/10.1002/hon.2379.
       Full Text  Link to Item
    • Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57. https://doi.org/10.1016/j.bbmt.2017.04.001.
       Full Text  Link to Item
    • Tuchman, Sascha A., Joseph O. Moore, Carlos D. DeCastro, Zhiguo Li, Emily Sellars, Yubin Kang, Gwynn Long, and Cristina G. Gasparetto. “Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone ("VCD-Lite") in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma.” J Geriatr Oncol 8, no. 3 (May 2017): 165–69. https://doi.org/10.1016/j.jgo.2017.02.004.
       Full Text  Link to Item
    • Sivaraj, Dharshan, Michael M. Green, Zhiguo Li, Anthony D. Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D. Long, et al. “Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.” Biol Blood Marrow Transplant 23, no. 2 (February 2017): 262–68. https://doi.org/10.1016/j.bbmt.2016.11.010.
       Full Text  Link to Item
    • Sung, Anthony D., Julia A. M. Sung, Samantha Thomas, Terry Hyslop, Cristina Gasparetto, Gwynn Long, David Rizzieri, et al. “Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.” Clin Infect Dis 63, no. 8 (October 15, 2016): 999–1006. https://doi.org/10.1093/cid/ciw451.
       Full Text  Link to Item
    • Green, Michael M. B., Nelson Chao, Saurabh Chhabra, Kelly Corbet, Cristina Gasparetto, Ari Horwitz, Zhiguo Li, et al. “Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.” J Hematol Oncol 9, no. 1 (August 17, 2016): 71. https://doi.org/10.1186/s13045-016-0301-2.
       Full Text  Open Access Copy  Link to Item
    • Tuchman, Sascha A., Wendi A. Bacon, Li-Wen Huang, Gwynn Long, David Rizzieri, Mitchell Horwitz, John P. Chute, et al. “Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.” J Clin Apher 30, no. 3 (June 2015): 176–82. https://doi.org/10.1002/jca.21360.
       Full Text  Link to Item
    • Tuchman, Sascha A., Amy Lane, Whitney E. Hornsby, Caroline Bishop, Samantha Thomas, James E. Herndon, Gwynn Long, Cristina Gasparetto, and Lee W. Jones. “Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study.” Clin Lymphoma Myeloma Leuk 15, no. 2 (February 2015): 103–9. https://doi.org/10.1016/j.clml.2014.09.002.
       Full Text  Link to Item
    • Long, Gwynn, Edmund K. Waller, Steven Gregurek, Guido Tricot, Susanne Marschner, and Jerry Bill. “Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.” J Clin Apher 30, no. 1 (February 2015): 1–7. https://doi.org/10.1002/jca.21341.
       Full Text  Link to Item
    • Horwitz, Mitchell E., Nelson J. Chao, David A. Rizzieri, Gwynn D. Long, Keith M. Sullivan, Cristina Gasparetto, John P. Chute, et al. “Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.” J Clin Invest 124, no. 7 (July 2014): 3121–28. https://doi.org/10.1172/JCI74556.
       Full Text  Open Access Copy  Link to Item
    • Kanda, Junya, Gwynn D. Long, Cristina Gasparetto, Mitchell E. Horwitz, Keith M. Sullivan, John P. Chute, Ashley Morris, et al. “Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.” Biol Blood Marrow Transplant 20, no. 2 (February 2014): 257–63. https://doi.org/10.1016/j.bbmt.2013.11.010.
       Full Text  Link to Item
    • Kanda, J., L. Kaynar, Y. Kanda, V. K. Prasad, S. H. Parikh, L. Lan, T. Shen, et al. “Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.” Bone Marrow Transplant 48, no. 7 (July 2013): 926–31. https://doi.org/10.1038/bmt.2012.279.
       Full Text  Open Access Copy  Link to Item
    • Held, Lauren A., David Rizzieri, Gwynn D. Long, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Mitchell E. Horwitz, Nelson J. Chao, and Cristina Gasparetto. “A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.” Cancer Invest 31, no. 3 (March 2013): 172–76. https://doi.org/10.3109/07357907.2012.756109.
       Full Text  Link to Item
    • Spasojevic, Ivan, Ligia R. S. da Costa, Mitchell E. Horwitz, Gwynn D. Long, Keith M. Sullivan, John P. Chute, Cristina Gasparetto, Ashley Morris, Nelson J. Chao, and David A. Rizzieri. “Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.” Cancer Invest 30, no. 9 (November 2012): 679–82. https://doi.org/10.3109/07357907.2012.726386.
       Full Text  Link to Item
    • Kanda, Junya, Lun-Wei Chiou, Paul Szabolcs, Gregory D. Sempowski, David A. Rizzieri, Gwynn D. Long, Keith M. Sullivan, et al. “Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.” Biol Blood Marrow Transplant 18, no. 11 (November 2012): 1664-1676.e1. https://doi.org/10.1016/j.bbmt.2012.06.005.
       Full Text  Link to Item
    • Jagasia, M. H., R. Abonour, G. D. Long, B. J. Bolwell, G. G. Laport, T. B. Shore, S. Durrant, et al. “Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial.” Bone Marrow Transplant 47, no. 10 (October 2012): 1350–55. https://doi.org/10.1038/bmt.2011.261.
       Full Text  Link to Item
    • Horwitz, M. E., G. Long, P. Holman, E. Libby, G. C. Calandra, and J. R. Schriber. “Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors.” Bone Marrow Transplant 47, no. 10 (October 2012): 1283–86. https://doi.org/10.1038/bmt.2012.21.
       Full Text  Link to Item
    • Horwitz, M. E., J. P. Chute, C. Gasparetto, G. D. Long, C. McDonald, A. Morris, D. A. Rizzieri, K. M. Sullivan, and N. J. Chao. “Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.” Bone Marrow Transplant 47, no. 8 (August 2012): 1051–55. https://doi.org/10.1038/bmt.2011.217.
       Full Text  Link to Item
    • Chen, D. -. F., V. K. Prasad, G. Broadwater, N. L. Reinsmoen, A. DeOliveira, A. Clark, K. M. Sullivan, et al. “Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.” Bone Marrow Transplant 47, no. 6 (June 2012): 817–23. https://doi.org/10.1038/bmt.2011.181.
       Full Text  Link to Item
    • Kanda, J., M. E. Horwitz, G. D. Long, C. Gasparetto, K. M. Sullivan, J. P. Chute, A. Morris, et al. “Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.” Bone Marrow Transplant 47, no. 5 (May 2012): 700–705. https://doi.org/10.1038/bmt.2011.158.
       Full Text  Link to Item
    • Kanda, Junya, David A. Rizzieri, Cristina Gasparetto, Gwynn D. Long, John P. Chute, Keith M. Sullivan, Ashley Morris, et al. “Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.” Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867–74. https://doi.org/10.1016/j.bbmt.2010.09.009.
       Full Text  Link to Item
    • Craciunescu, Oana I., Beverly A. Steffey, Chris R. Kelsey, Nicole A. Larrier, Cathy J. Paarz-Largay, Robert G. Prosnitz, Nelson Chao, et al. “Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.” Int J Radiat Oncol Biol Phys 79, no. 4 (March 15, 2011): 1248–55. https://doi.org/10.1016/j.ijrobp.2010.05.036.
       Full Text  Link to Item
    • Rizzieri, David A., Christopher Crout, Robert Storms, Jared Golob, Gwynn D. Long, Cristina Gasparetto, Keith M. Sullivan, et al. “Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.” Cancer Invest 29, no. 1 (January 2011): 56–61. https://doi.org/10.3109/07357907.2010.535055.
       Full Text  Link to Item
    • Rizzieri, David A., Robert Storms, Dong-Feng Chen, Gwynn Long, Yiping Yang, Daniel A. Nikcevich, Cristina Gasparetto, et al. “Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.” Biol Blood Marrow Transplant 16, no. 8 (August 2010): 1107–14. https://doi.org/10.1016/j.bbmt.2010.02.018.
       Full Text  Link to Item
    • Crout, Christopher A., Liang-Piu Koh, Jon P. Gockerman, Joseph O. Moore, Carlos Decastro, Gwynn D. Long, Louis Diehl, et al. “Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.” Cancer Invest 28, no. 6 (July 2010): 654–60. https://doi.org/10.3109/07357901003631015.
       Full Text  Link to Item
    • Gasparetto, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Gwynn D. Long, Mitchell E. Horwitz, et al. “"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.” Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70–77. https://doi.org/10.1016/j.bbmt.2009.08.017.
       Full Text  Link to Item
    • Rizzieri, D. A., P. Dev, G. D. Long, C. Gasparetto, K. M. Sullivan, Ml Horwitz, J. Chute, and N. J. Chao. “Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.” Bone Marrow Transplant 43, no. 4 (February 2009): 327–33. https://doi.org/10.1038/bmt.2008.321.
       Full Text  Link to Item
    • Horwitz, Mitchell E., Ashley Morris, Cristina Gasparetto, Keith Sullivan, Gwynn Long, John Chute, David Rizzieri, Jackie McPherson, and Nelson Chao. “Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.” Biol Blood Marrow Transplant 14, no. 5 (May 2008): 591–94. https://doi.org/10.1016/j.bbmt.2008.02.016.
       Full Text  Link to Item
    • Byrne, B. J., M. Horwitz, G. D. Long, C. Gasparetto, K. M. Sullivan, J. Chute, N. J. Chao, and D. A. Rizzieri. “Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection.” Bone Marrow Transplant 41, no. 1 (January 2008): 39–43. https://doi.org/10.1038/sj.bmt.1705882.
       Full Text  Link to Item
    • Horwitz, Mitchell E., Ivan Spasojevic, Ashley Morris, Marilyn Telen, James Essell, Cristina Gasparetto, Keith Sullivan, et al. “Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.” Biol Blood Marrow Transplant 13, no. 12 (December 2007): 1422–26. https://doi.org/10.1016/j.bbmt.2007.08.050.
       Full Text  Link to Item
    • Hanson, Kimberly E., L Barth Reller, Joanne Kurtzberg, Mitchell Horwitz, Gwynn Long, and Barbara D. Alexander. “Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients.” J Clin Microbiol 45, no. 6 (June 2007): 1972–73. https://doi.org/10.1128/JCM.02515-06.
       Full Text  Link to Item
    • Rizzieri, David A., Liang Piu Koh, Gwynn D. Long, Cristina Gasparetto, Keith M. Sullivan, Mitchell Horwitz, John Chute, et al. “Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.” J Clin Oncol 25, no. 6 (February 20, 2007): 690–97. https://doi.org/10.1200/JCO.2006.07.0953.
       Full Text  Link to Item
    • Lagoo, Anand S., Jerald Z. Gong, Timothy T. Stenzel, Barbara K. Goodman, Patrick J. Buckley, Nelson J. Chao, Cristina Gasparetto, Gwynn D. Long, and David A. Rizzieri. “Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment.” Arch Pathol Lab Med 130, no. 10 (October 2006): 1479–88. https://doi.org/10.5858/2006-130-1479-MEOSBM.
       Full Text  Link to Item
    • Alexander, Barbara D., Wiley A. Schell, Jackie L. Miller, Gwynn D. Long, and John R. Perfect. “Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.” Transplantation 80, no. 6 (September 27, 2005): 868–71. https://doi.org/10.1097/01.tp.0000173771.47698.7b.
       Full Text  Link to Item
    • Chao, Nelson J., Liang-Piu Koh, Gwynn D. Long, Cristina Gasparetto, Mitchell Horwitz, Ashley Morris, Martha Lassiter, Keith M. Sullivan, and David A. Rizzieri. “Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens.” Biol Blood Marrow Transplant 10, no. 8 (August 2004): 569–75. https://doi.org/10.1016/j.bbmt.2004.05.001.
       Full Text  Link to Item
    • Rizzieri, David A., Gregory J. Sand, Dean McGaughey, Joseph O. Moore, Carlos DeCastro, Nelson J. Chao, James J. Vredenburgh, et al. “Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.” Cancer 100, no. 11 (June 1, 2004): 2408–14. https://doi.org/10.1002/cncr.20245.
       Full Text  Link to Item
    • Long, Gwynn D., Mary Laughlin, Bella Madan, Joanne Kurtzberg, Cristina Gasparetto, Ashley Morris, David Rizzieri, et al. “Unrelated umbilical cord blood transplantation in adult patients.” Biol Blood Marrow Transplant 9, no. 12 (December 2003): 772–80. https://doi.org/10.1016/j.bbmt.2003.08.007.
       Full Text  Link to Item
    • Rizzieri, David A., Jeffrey T. Talbot, Gwynn D. Long, James J. Vredenburgh, Christina Gasparetto, Clayton S. Smith, Michael O. Colvin, et al. “4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.” Biol Blood Marrow Transplant 9, no. 3 (March 2003): 183–88. https://doi.org/10.1053/bbmt.2003.50011.
       Full Text  Link to Item
    • Rizzieri, David A., Valerie K. Ibom, Joseph O. Moore, Carlos M. DeCastro, Gary L. Rosner, David J. Adams, Traci Foster, et al. “Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.” Clin Cancer Res 9, no. 2 (February 2003): 663–68.
       Link to Item
    • McCune, Steven L., Jon P. Gockerman, Joseph O. Moore, Carlos M. Decastro, Adam J. Bass, Nelson J. Chao, Gwynn D. Long, et al. “Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.” Leuk Lymphoma 43, no. 5 (May 2002): 1007–11. https://doi.org/10.1080/10428190290021597.
       Full Text  Link to Item
    • Gasparetto, Cristina, Maura Gasparetto, Michael Morse, Barbara Rooney, James J. Vredenburgh, Gwynn D. Long, David A. Rizzieri, Jennifer Loftis, Nelson J. Chao, and Clay Smith. “Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF.” Cytokine 18, no. 1 (April 7, 2002): 8–19. https://doi.org/10.1006/cyto.2002.1009.
       Full Text  Link to Item
    • Garantziotis, Stavros, Karan S. Bhalla, Gwynn D. Long, James J. Vredenburgh, and Rodney J. Folz. “Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant.” Respiration 69, no. 4 (2002): 351–54. https://doi.org/10.1159/000063260.
       Full Text  Link to Item
    • Stuart, Monic J., William P. Peters, Gloria Broadwater, Atif Hussein, Maureen Ross, Lawrence B. Marks, Rodney J. Folz, et al. “High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes.” Biol Blood Marrow Transplant 8, no. 12 (2002): 666–73. https://doi.org/10.1053/bbmt.2002.v8.abbmt080666.
       Full Text  Link to Item
    • Chao, Nelson J., Cong X. Liu, Barbara Rooney, Benny J. Chen, Gwynn D. Long, James J. Vredenburgh, Ashley Morris, Cristina Gasparetto, and David A. Rizzieri. “Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells.” Biol Blood Marrow Transplant 8, no. 5 (2002): 249–56. https://doi.org/10.1053/bbmt.2002.v8.pm12064361.
       Full Text  Link to Item
    • Rizzieri, D. A., G. D. Long, J. J. Vredenburgh, C. Gasparetto, A. Morris, T. T. Stenzel, P. Davis, and N. J. Chao. “Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.” Blood 98, no. 12 (December 1, 2001): 3486–88. https://doi.org/10.1182/blood.v98.12.3486.
       Full Text  Link to Item
    • Deeg, H. J., B. R. Blazar, B. J. Bolwell, G. D. Long, F. Schuening, J. Cunningham, R. M. Rifkin, et al. “Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.” Blood 98, no. 7 (October 1, 2001): 2052–58. https://doi.org/10.1182/blood.v98.7.2052.
       Full Text  Link to Item
    • Maddox, L., G. D. Long, J. J. Vredenburgh, and R. J. Folz. “Rhizopus presenting as an endobronchial obstruction following bone marrow transplant.” Bone Marrow Transplant 28, no. 6 (September 2001): 634–36. https://doi.org/10.1038/sj.bmt.1703191.
       Full Text  Link to Item
    • Bhagat, R., T. A. Sporn, G. D. Long, and R. J. Folz. “Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.” Bone Marrow Transplant 27, no. 10 (May 2001): 1109–11. https://doi.org/10.1038/sj.bmt.1703039.
       Full Text  Link to Item
    • Horning, S. J., R. S. Negrin, R. T. Hoppe, S. A. Rosenberg, N. J. Chao, G. D. Long, B. W. Brown, and K. G. Blume. “High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.” Blood 97, no. 2 (January 15, 2001): 404–9. https://doi.org/10.1182/blood.v97.2.404.
       Full Text  Link to Item
    • McGaughey, D. S., D. A. Nikcevich, G. D. Long, J. J. Vredenburgh, D. Rizzieri, C. A. Smith, G. Broadwater, et al. “Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.” Biol Blood Marrow Transplant 7, no. 5 (2001): 274–78. https://doi.org/10.1053/bbmt.2001.v7.pm11400949.
       Full Text  Link to Item
    • Stuart, M. J., N. S. Chao, S. J. Horning, R. M. Wong, R. S. Negrin, L. J. Johnston, J. A. Shizuru, G. D. Long, K. G. Blume, and K. E. Stockerl-Goldstein. “Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.” Biol Blood Marrow Transplant 7, no. 10 (2001): 552–60. https://doi.org/10.1016/s1083-8791(01)70015-8.
       Full Text  Link to Item
    • Alvarnas, J. C., R. S. Negrin, S. J. Horning, W. W. Hu, G. D. Long, J. R. Schriber, K. Stockerl-Goldstein, et al. “High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.” Biol Blood Marrow Transplant 6, no. 3A (2000): 352–58. https://doi.org/10.1016/s1083-8791(00)70060-7.
       Full Text  Link to Item
    • Chao, N. J., D. S. Snyder, M. Jain, R. M. Wong, J. C. Niland, R. S. Negrin, G. D. Long, et al. “Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.” Biol Blood Marrow Transplant 6, no. 3 (2000): 254–61. https://doi.org/10.1016/s1083-8791(00)70007-3.
       Full Text  Link to Item
    • Hu, W. W., R. S. Negrin, K. Stockerl-Goldstein, L. J. Johnston, J. A. Shizuru, R. M. Wong, N. J. Chao, G. D. Long, R. H. Feiner, and K. G. Blume. “Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy.” Biol Blood Marrow Transplant 6, no. 1 (2000): 58–69. https://doi.org/10.1016/s1083-8791(00)70053-x.
       Full Text  Link to Item
    • Stockerl-Goldstein, K. E., S. A. Reddy, S. F. Horning, K. G. Blume, N. F. Chao, W. W. Hu, L. F. Johnston, et al. “Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.” Biol Blood Marrow Transplant 6, no. 5 (2000): 506–12. https://doi.org/10.1016/s1083-8791(00)70021-8.
       Full Text  Link to Item
    • Hu, W. W., G. D. Long, K. E. Stockerl-Goldstein, L. J. Johnston, N. J. Chao, R. S. Negrin, and K. G. Blume. “A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.” Clin Cancer Res 5, no. 11 (November 1999): 3411–18.
       Link to Item
    • Rizzieri, D. A., J. J. Vredenburgh, R. Jones, M. Ross, E. J. Shpall, A. Hussein, G. Broadwater, et al. “Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.” J Clin Oncol 17, no. 10 (October 1999): 3064–74. https://doi.org/10.1200/JCO.1999.17.10.3064.
       Full Text  Link to Item
    • Shpall, E. J., C. A. Wheeler, S. A. Turner, S. Yanovich, R. A. Brown, A. L. Pecora, T. C. Shea, et al. “A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.” Blood 93, no. 8 (April 15, 1999): 2491–2501.
       Link to Item
    • Ross, M., G. M. Schmidt, J. C. Niland, M. D. Amylon, A. C. Dagis, G. D. Long, A. P. Nademanee, et al. “Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.” Biol Blood Marrow Transplant 5, no. 5 (1999): 285–91. https://doi.org/10.1016/s1083-8791(99)70003-0.
       Full Text  Link to Item
    • Long, G. D., M. D. Amylon, K. E. Stockerl-Goldstein, R. S. Negrin, N. J. Chao, W. W. Hu, A. P. Nademanee, et al. “Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.” Biol Blood Marrow Transplant 3, no. 6 (December 1997): 324–30.
       Link to Item
    • Long, G. D. “Renal cell carcinoma.” Curr Opin Oncol 9, no. 3 (May 1997): 301–6. https://doi.org/10.1097/00001622-199709030-00014.
       Full Text  Link to Item
    • Horning, S. J., N. J. Chao, R. S. Negrin, R. T. Hoppe, G. D. Long, W. W. Hu, R. M. Wong, B. W. Brown, and K. G. Blume. “High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.” Blood 89, no. 3 (February 1, 1997): 801–13.
       Link to Item
    • Kusnierz-Glaz, C. R., P. G. Schlegel, R. M. Wong, J. R. Schriber, N. J. Chao, M. D. Amylon, W. W. Hu, et al. “Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.” J Clin Oncol 15, no. 1 (January 1997): 18–25. https://doi.org/10.1200/JCO.1997.15.1.18.
       Full Text  Link to Item
    • Hausdorff, J., E. Davis, G. Long, R. Hoppe, M. van der Pas, C. Lassman, O. Kamel, and C. Jacobs. “Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.” Cancer J Sci Am 3, no. 5 (1997): 303–11.
       Link to Item
    • Long, G. D., N. J. Chao, W. W. Hu, R. S. Negrin, R. M. Wong, and K. G. Blume. “High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma.” Cancer 78, no. 12 (December 15, 1996): 2502–9. https://doi.org/10.1002/(sici)1097-0142(19961215)78:12<2502::aid-cncr9>3.0.co;2-l.
       Full Text  Link to Item
    • Chao, N. J., P. M. Parker, J. C. Niland, R. M. Wong, A. Dagis, G. D. Long, A. P. Nademanee, et al. “Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.” Biol Blood Marrow Transplant 2, no. 2 (May 1996): 86–92.
       Link to Item
    • Stockerl-Goldstein, K. E., S. J. Horning, R. S. Negrin, N. J. Chao, W. W. Hu, G. D. Long, R. T. Hoppe, et al. “Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.” Biol Blood Marrow Transplant 2, no. 2 (May 1996): 76–85.
       Link to Item
    • O’Donnell, M. R., G. D. Long, P. M. Parker, J. Niland, A. Nademanee, M. Amylon, N. Chao, R. S. Negrin, G. M. Schmidt, and M. L. Slovak. “Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.” J Clin Oncol 13, no. 12 (December 1995): 2973–79. https://doi.org/10.1200/JCO.1995.13.12.2973.
       Full Text  Link to Item
    • Parker, P. M., N. Chao, A. Nademanee, M. R. O’Donnell, G. M. Schmidt, D. S. Snyder, A. S. Stein, et al. “Thalidomide as salvage therapy for chronic graft-versus-host disease.” Blood 86, no. 9 (November 1, 1995): 3604–9.
       Link to Item
    • Burns, J. M., D. K. Tierney, G. D. Long, S. C. Lambert, and B. E. Carr. “Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting.” Oncol Nurs Forum 22, no. 8 (September 1995): 1219–24.
       Link to Item
    • Long, G. D., R. S. Negrin, C. F. Hoyle, C. R. Kusnierz-Glaz, J. R. Schriber, K. G. Blume, and N. J. Chao. “Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.” Cancer 76, no. 5 (September 1, 1995): 860–68. https://doi.org/10.1002/1097-0142(19950901)76:5<860::aid-cncr2820760521>3.0.co;2-b.
       Full Text  Link to Item
    • Negrin, R. S., C. R. Kusnierz-Glaz, B. J. Still, J. R. Schriber, N. J. Chao, G. D. Long, C. Hoyle, W. W. Hu, S. J. Horning, and B. W. Brown. “Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.” Blood 85, no. 11 (June 1, 1995): 3334–41.
       Link to Item
    • Chao, N. J., H. Kastrissios, G. D. Long, R. S. Negrin, S. J. Horning, R. M. Wong, T. F. Blaschke, and K. G. Blume. “A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.” Cancer 75, no. 6 (March 15, 1995): 1354–59. https://doi.org/10.1002/1097-0142(19950315)75:6<1354::aid-cncr2820750618>3.0.co;2-m.
       Full Text  Link to Item
    • Peters, W. P., J. W. Fay, H. K. Holland, T. Ahmed, B. J. Bolwell, J. Wolf, L. Damon, et al. “Autologous bone marrow transplantation in primary breast cancer: The American experience.” Bone Marrow Transplantation 15, no. SUPPL. 1 (January 1, 1995).
    • Horning, S. J., R. S. Negrin, J. C. Chao, G. D. Long, R. T. Hoppe, and K. G. Blume. “Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.” J Clin Oncol 12, no. 12 (December 1994): 2552–58. https://doi.org/10.1200/JCO.1994.12.12.2552.
       Full Text  Link to Item
    • Schriber, J. R., N. J. Chao, G. D. Long, R. S. Negrin, D. K. Tierney, C. Kusnierz-Glaz, K. S. Lucas, and K. G. Blume. “Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.” Blood 84, no. 5 (September 1, 1994): 1680–84.
       Link to Item
    • Snyder, D. S., R. S. Negrin, M. R. O’Donnell, N. J. Chao, M. D. Amylon, G. D. Long, A. P. Nademanee, et al. “Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.” Blood 84, no. 5 (September 1, 1994): 1672–79. https://doi.org/10.1182/blood.v84.5.1672.bloodjournal8451672.
       Full Text
    • Snyder, D. S., R. S. Negrin, M. R. O’Donnell, N. J. Chao, M. D. Amylon, G. D. Long, A. P. Nademanee, A. S. Stein, P. M. Parker, and E. P. Smith. “Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.” Blood 84, no. 5 (September 1, 1994): 1672–79.
       Link to Item
    • Chao, N. J., J. R. Schriber, G. D. Long, R. S. Negrin, M. Catolico, B. W. Brown, L. L. Miller, and K. G. Blume. “A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.” Blood 83, no. 10 (May 15, 1994): 2823–28.
       Link to Item
    • Blume, K. G., G. D. Long, R. S. Negrin, N. J. Chao, C. Kusnierz-Glaz, and M. D. Amylon. “Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.” Bone Marrow Transplant 14 Suppl 4 (1994): S9-10.
       Link to Item
    • Snyder, D. S., N. J. Chao, M. D. Amylon, J. Taguchi, G. D. Long, R. S. Negrin, A. P. Nademanee, M. R. O’Donnell, G. M. Schmidt, and A. S. Stein. “Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.” Blood 82, no. 9 (November 1, 1993): 2920–28.
       Link to Item
    • Chao, N. J., G. M. Schmidt, J. C. Niland, M. D. Amylon, A. C. Dagis, G. D. Long, A. P. Nademanee, R. S. Negrin, M. R. O’Donnell, and P. M. Parker. “Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.” N Engl J Med 329, no. 17 (October 21, 1993): 1225–30. https://doi.org/10.1056/NEJM199310213291703.
       Full Text  Link to Item
    • Schriber, J. R., R. S. Negrin, N. J. Chao, G. D. Long, S. J. Horning, and K. G. Blume. “The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.” Leukemia 7, no. 10 (October 1993): 1491–95.
       Link to Item
    • Chao, N. J., J. R. Schriber, K. Grimes, G. D. Long, R. S. Negrin, C. M. Raimondi, S. J. Horning, S. L. Brown, L. Miller, and K. G. Blume. “Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.” Blood 81, no. 8 (April 15, 1993): 2031–35.
       Link to Item
    • Chao, N. J., A. S. Stein, G. D. Long, R. S. Negrin, M. D. Amylon, R. M. Wong, S. J. Forman, and K. G. Blume. “Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia.” Blood 81, no. 2 (January 15, 1993): 319–23.
       Link to Item
    • Chao, N. J., D. K. Tierney, J. R. Bloom, G. D. Long, T. A. Barr, B. A. Stallbaum, R. M. Wong, R. S. Negrin, S. J. Horning, and K. G. Blume. “Dynamic assessment of quality of life after autologous bone marrow transplantation.” Blood 80, no. 3 (August 1, 1992): 825–30.
       Link to Item
    • Lazarus, H. M., L. T. Goodnough, E. Goldwasser, G. Long, J. L. Arnold, and K. P. Strohl. “Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.” Bone Marrow Transplant 10, no. 1 (July 1992): 71–75.
       Link to Item
    • Chao, N. J., G. D. Long, R. S. Negrin, J. R. Schriber, C. M. Raimondi, S. L. Brown, and K. G. Blume. “G-CSF and peripheral blood progenitor cells.” Lancet 339, no. 8806 (June 6, 1992): 1410.
       Link to Item
    • Chao, N. J., A. P. Nademanee, G. D. Long, G. M. Schmidt, T. A. Donlon, P. Parker, M. L. Slovak, L. S. Nagasawa, K. G. Blume, and S. J. Forman. “Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.” J Clin Oncol 9, no. 9 (September 1991): 1575–79. https://doi.org/10.1200/JCO.1991.9.9.1575.
       Full Text  Link to Item
    • Chao, N. J., S. R. Duncan, G. D. Long, S. J. Horning, and K. G. Blume. “Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.” Ann Intern Med 114, no. 2 (January 15, 1991): 145–46. https://doi.org/10.7326/0003-4819-114-2-145.
       Full Text  Link to Item
    • Horning, S. J., N. J. Chao, R. S. Negrin, R. T. Hoppe, L. W. Kwak, G. D. Long, B. Stallbaum, P. O’Connor, and K. G. Blume. “The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data.” Ann Oncol 2 Suppl 1 (January 1991): 47–50. https://doi.org/10.1093/annonc/2.suppl_1.47.
       Full Text  Link to Item
    • Chao, N. J., M. D. Amylon, G. D. Long, R. S. Negrin, R. T. Hoppe, S. J. Horning, and K. G. Blume. “Bone marrow transplantation for hematologic malignancies: the Stanford experience.” Clin Transpl, 1990, 157–63.
       Link to Item
    • DeChatelet, L. R., G. D. Long, P. S. Shirley, D. A. Bass, M. J. Thomas, F. W. Henderson, and M. S. Cohen. “Mechanism of the luminol-dependent chemiluminescence of human neutrophils.” J Immunol 129, no. 4 (October 1982): 1589–93.
       Link to Item
    • Long, G. D., L. R. DeChatelet, and M. J. Thomas. “Mechanism of luminol enhancement of neutrophil chemiluminescence (CL).” Clinical Research 30, no. 2 (January 1, 1982).
    • Long, G. D., L. R. DeChatelet, J. T. O’Flaherty, C. E. McCall, D. A. Bass, P. S. Shirley, and J. W. Parce. “Effects of quercetin on magnesium-dependent adenosine triphosphatase and the metabolism of human polymorphonuclear leukocytes.” Blood 57, no. 3 (March 1981): 561–66.
       Link to Item
    • Long, G., L. R. DeChatelet, C. E. McCall, D. A. Bass, and M. R. Cooper. “Distinction between alkaline phosphatase and Mg2+-ATPase of the human polymorphonuclear leukocyte.” Biochem Med 22, no. 1 (August 1979): 88–97. https://doi.org/10.1016/0006-2944(79)90041-3.
       Full Text  Link to Item

  • Conference Papers

    • Smith, Patrick J., Meagan Lew, Yen Lowder, Kristi Romero, Jillian C. Thompson, Lauren Bohannon, Alyssa Pittman, et al. “Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.” In Bone Marrow Transplant, 57:89–94, 2022. https://doi.org/10.1038/s41409-021-01470-z.
       Full Text  Link to Item
    • Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.” In Biol Blood Marrow Transplant, 23:1949–54, 2017. https://doi.org/10.1016/j.bbmt.2017.06.027.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.